News and Events
Former CODR graduate student Abhi Sathe was recently promoted to Senior Clinical Pharmacologist at Gilead Sciences. He was mentored by Drs. Cloyd and Coles during his time with CODR and credits the training he received as a key part of his professional success. Congratulations Dr. Sathe!
Congratulations to the CODR faculty and staff who were recognized at the College of Pharmacy's Awards & Recognition Program on 1/11/2022!
- Jim Cloyd - Special Merit Faculty Research Award; Special Merit Faculty Teaching and Mentoring Award; 45 Years of Service Recognition
- Lori Endsley - Meritorious Service Award
- Reena Kartha - Special Merit Faculty Research Award; Above and Beyond Award
As part of her being named a Rare Disease Difference Maker, Dr. Reena Kartha was interviewed by Engage Health. She shared her path to the rare disease field and more about her innovative undergraduate course which was a huge factor to her being nominated.
The National Organization for Rare Disorders (NORD) has selected the University of Minnesota and 30 others to become designated as Rare Disease Centers of Excellence
Siddhee Sahasrabudhe, CODR graduate student, earned two additional certificates recently: NIH ethics and regulatory affairs and TACA pharmacometrics statistics.
CODR’s commercial partner, Allaysis, has submitted a New Drug Application (NDA) to the FDA for an intravenous baclofen product. If there are no hitches in the review process, the product will be available for marketing in late 2022. The development of this product, which is an orphan drug, has provided important financial support for CODR in the form of graduate student stipends and multiple published peer-reviewed papers.
Dr. Krach, an affiliate member of CODR, was recently awarded the Gabriella E. Molnar-Swaffort Pediatric PM&R Lifetime Achievement Award for her work as an educator, advocate and skilled provider for patients diagnosed with spina bifida and cerebral palsy. Congratulations Dr. Krach for this prestigious and well deserved award!
The FDA, NIH, 10 pharmaceutical companies, and 5 nonprofit organizations have partnered to accelerate development of gene therapies for the 30 million Americans with rare diseases. Of approximately 7,000 rare diseases, only 2 currently have FDA-approved gene therapies.
Congratulations to Sruthi Subramanian on earning a 2021 Empower Scholarship from Courage Kenny. This award supports students of color who are pursuing careers in a medical or rehabilitation field. Sruthi is a freshman at the University of Minnesota with an interdisciplinary major in Biology, Society and the Environment with a goal of becoming a pediatric Neurologist. She created an eleven-minute video recognizing the 30th anniversary of the Americans with Disabilities Act and has been active with CODR.
Global Genes is hosting Dr. Reena Kartha for one of their Ask Me Anything sessions on October 27, 12:30pm EST. Dr. Kartha's course on Rare Diseases: What it Takes to be a Medical Orphan, her research on oxidative stress and rare inherited metabolic disorders, and CODR's collaboration with the Dept. of Theater Arts and Dance to produce a play that examines the challenges of those living with rare disorders are all being highlighted.